Management and Executive

Ataraxis AI: $20.4 Million (Series A) Raised For Transforming Precision Medicine In Cancer Care

Ataraxis AI Raises $20.4 Million in Series A Led by AIX Ventures

Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A

#NYCtech Week in Review: 1/5/25 – 1/11/25

Research Scientist

Ataraxis is an AI precision medicine company transforming cancer diagnostics and patient outcomes through the power of AI. The Research Scientist will design and implement advanced machine learning models, collaborate with a multidisciplinary team, and contribute to research publications.

Sign up with Google

Sign in with Google